Transdermal Skin Patches Market is Estimated to Witness High Growth...

Transdermal Skin Patches Market is Estimated to Witness High Growth Owing to Advancements in Drug Delivery Technologies

Postado 2024-06-28 14:17:52

701

Transdermal skin patches are adhesive patches placed on the skin to deliver substances such as medicines into the body through the skin at a controlled rate over a predetermined period of time. They provide advantages like continuous dosing, reduced dosing frequency, and improved patient compliance. Transdermal delivery finds applications in therapeutic areas like pain management, smoking cessation, contraception, and others.

The Global Transdermal Skin Patches Market is estimated to be valued at US$ 9773.27 Bn in 2024 and is expected to exhibit a CAGR of 23% over the forecast period 2024 To 2031.

Key Takeaways
Key players operating in the Transdermal Skin Patches are Omsk Carbon Group, Tokai Carbon Co., Ltd., Atlas Organics Private Limited, Continental Carbon Company, Birla Carbon, Cabot Corporation, International China Oak Investment Holdings Co., Ltd., Himadri Speciality Chemical Ltd, Philips Carbon Black Limited, Orion Engineered Carbons GmbH, Ralson.

Key opportunities in the Transdermal Skin Patches Market Size include increasing market penetration in emerging economies, development of new therapeutic areas such as neurological disorders, and growing demand for transdermal drug delivery in pediatric and geriatric patients.

Advancements in polymer and formulation technologies are enabling transdermal patches with sophisticated features like printed electronics for smart products, microneedles for improved drug delivery, and adhesive technologies for enhanced adhesion and wearability.

Market drivers
The key drivers for the growth of transdermal skin patches market include rising prevalence of conditions requiring long-term medication like chronic pain and diabetes, growing demand for self-administrable drug delivery systems, and advantages of transdermal delivery over oral administration like avoidance of first-pass metabolism and sustained release of drugs. Improving availability of generic transdermal patches following patent expirations is also expected to boost the market growth.
Current Challenges in the Transdermal Skin Patches Market
The transdermal skin patches market is facing various challenges including stringent regulatory approval process, biocompatibility issues, and poor wearability of patches. The approval process for transdermal patches involves multiple clinical trials which are highly expensive and time consuming. There are also challenges in maintaining the stability of drugs and ensuring precise drug delivery over an extended period of time through patches. The adhesion of patches to skin varies from person to person depending on their age, skin type and condition which affects the wearability and efficacy.

Get more insights on – Transdermal Skin Patches Market